Year |
Citation |
Score |
2009 |
Chervin AS, Stone JD, Holler PD, Bai A, Chen J, Eisen HN, Kranz DM. The impact of TCR-binding properties and antigen presentation format on T cell responsiveness. Journal of Immunology (Baltimore, Md. : 1950). 183: 1166-78. PMID 19553539 DOI: 10.4049/Jimmunol.0900054 |
0.781 |
|
2007 |
Holler PD, Yamagata T, Jiang W, Feuerer M, Benoist C, Mathis D. The same genomic region conditions clonal deletion and clonal deviation to the CD8alphaalpha and regulatory T cell lineages in NOD versus C57BL/6 mice. Proceedings of the National Academy of Sciences of the United States of America. 104: 7187-92. PMID 17438291 DOI: 10.1073/Pnas.0701777104 |
0.386 |
|
2007 |
Brophy SE, Jones LL, Holler PD, Kranz DM. Cellular uptake followed by class I MHC presentation of some exogenous peptides contributes to T cell stimulatory capacity. Molecular Immunology. 44: 2184-94. PMID 17169430 DOI: 10.1016/J.Molimm.2006.11.016 |
0.718 |
|
2006 |
Ge Q, Holler PD, Mahajan VS, Nuygen T, Eisen HN, Chen J. Development of CD4+ T cells expressing a nominally MHC class I-restricted T cell receptor by two different mechanisms. Proceedings of the National Academy of Sciences of the United States of America. 103: 1822-7. PMID 16443680 DOI: 10.1073/Pnas.0510561103 |
0.501 |
|
2005 |
Chlewicki LK, Holler PD, Monti BC, Clutter MR, Kranz DM. High-affinity, peptide-specific T cell receptors can be generated by mutations in CDR1, CDR2 or CDR3. Journal of Molecular Biology. 346: 223-39. PMID 15663940 DOI: 10.1016/J.Jmb.2004.11.057 |
0.78 |
|
2004 |
Peng KW, Holler PD, Orr BA, Kranz DM, Russell SJ. Targeting virus entry and membrane fusion through specific peptide/MHC complexes using a high-affinity T-cell receptor. Gene Therapy. 11: 1234-9. PMID 15215883 DOI: 10.1038/Sj.Gt.3302286 |
0.739 |
|
2004 |
Holler PD, Kranz DM. T cell receptors: affinities, cross-reactivities, and a conformer model. Molecular Immunology. 40: 1027-31. PMID 15036906 DOI: 10.1016/J.Molimm.2003.11.013 |
0.704 |
|
2003 |
Leifert JA, Holler PD, Harkins S, Kranz DM, Whitton JL. The cationic region from HIV tat enhances the cell-surface expression of epitope/MHC class I complexes. Gene Therapy. 10: 2067-73. PMID 14595379 DOI: 10.1038/Sj.Gt.3302115 |
0.724 |
|
2003 |
Holler PD, Kranz DM. Quantitative analysis of the contribution of TCR/pepMHC affinity and CD8 to T cell activation. Immunity. 18: 255-64. PMID 12594952 DOI: 10.1016/S1074-7613(03)00019-0 |
0.716 |
|
2003 |
Brophy SE, Holler PD, Kranz DM. A yeast display system for engineering functional peptide-MHC complexes. Journal of Immunological Methods. 272: 235-46. PMID 12505727 DOI: 10.1016/S0022-1759(02)00439-8 |
0.742 |
|
2003 |
Holler PD, Chlewicki LK, Kranz DM. TCRs with high affinity for foreign pMHC show self-reactivity. Nature Immunology. 4: 55-62. PMID 12469116 DOI: 10.1038/Ni863 |
0.782 |
|
2001 |
Holler PD, Lim AR, Cho BK, Rund LA, Kranz DM. CD8(-) T cell transfectants that express a high affinity T cell receptor exhibit enhanced peptide-dependent activation. The Journal of Experimental Medicine. 194: 1043-52. PMID 11602635 DOI: 10.1084/Jem.194.8.1043 |
0.791 |
|
2000 |
Shusta EV, Holler PD, Kieke MC, Kranz DM, Wittrup KD. Directed evolution of a stable scaffold for T-cell receptor engineering. Nature Biotechnology. 18: 754-9. PMID 10888844 DOI: 10.1038/77325 |
0.774 |
|
2000 |
Holler PD, Holman PO, Shusta EV, O'Herrin S, Wittrup KD, Kranz DM. In vitro evolution of a T cell receptor with high affinity for peptide/MHC. Proceedings of the National Academy of Sciences of the United States of America. 97: 5387-92. PMID 10779548 DOI: 10.1073/Pnas.080078297 |
0.771 |
|
1999 |
Rund LA, Cho BK, Manning TC, Holler PD, Roy EJ, Kranz DM. Bispecific agents target endogenous murine T cells against human tumor xenografts. International Journal of Cancer. Journal International Du Cancer. 83: 141-9. PMID 10449621 DOI: 10.1002/(Sici)1097-0215(19990924)83:1<141::Aid-Ijc24>3.0.Co;2-0 |
0.647 |
|
Show low-probability matches. |